info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Amyloidosis

E4_AMYLOIDOSIS

amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E85
Cause of death: ICD-10 E85

2 out of 7 registries used, show all original rules.

554

diagram downward connector

Check minimum number of events None

554

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

554

diagram downward connector
E4_AMYLOIDOSIS

Control definitions

Control exclude E4_METABOLIA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E70-E90
Name in latin Amyloidosis

Summary Statistics

Key figures

All Female Male
Number of individuals 554 269 285
Unadjusted prevalence (%) 0.13 0.12 0.16
Mean age at first event (years) 63.67 58.97 68.10

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: E4_AMYLOIDOSIS – Amyloidosis
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Amyloidosis

Endpoint not on priority list, no data to show.